Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma
by
, ,
Gregory Baud
1,
Arnaud Jannin
2,
Camille Marciniak
1,
Benjamin Chevalier
2,
Christine Do Cao
2,
Emmanuelle Leteurtre
3,
Amandine Beron
4,
Georges Lion
4,
Samuel Boury
5,
Sebastien Aubert
3,
Brigitte Bouchindhomme
3,
Marie-Christine Vantyghem
2,
Robert Caiazzo
1 and
François Pattou
1,* 1
Department of Endocrine Surgery, CHU Lille, F-59000 Lille, France
2
Department of Endocrinology and Metabolism, CHU Lille, F-59000 Lille, France
3
Pathology Institute, Biology Pathology Center, CHU Lille, F-59000 Lille, France
4
Department of Nuclear Medicine, CHU Lille, F-59000 Lille, France
5
Department of Radiology, CHU Lille, F-59000 Lille, France
*
Author to whom correspondence should be addressed.
Cancers 2022, 14(21), 5462; https://0-doi-org.brum.beds.ac.uk/10.3390/cancers14215462
Submission received: 4 July 2022
/
Revised: 15 October 2022
/
Accepted: 31 October 2022
/
Published: 7 November 2022
(This article belongs to the Special Issue Management and Treatment of Endocrine Tumors)
Abstract
:Simple Summary
Thyroid cancers are the most common endocrine cancers and their incidence has increased significantly in recent decades worldwide. Total thyroidectomy is recognized as the gold standard treatment for thyroid cancers. However, controversies remain regarding lymph node dissection and the related morbidities. The aim of our retrospective study was to analyse the risk factors of post-thyroidectomy complications and to assess the morbidity of lymph node dissection, especially in the central neck compartment, since prophylactic central lymph node dissection has not been proven to bring an overall survival benefit. In a cohort of 1547 patients with thyroid carcinoma who underwent total thyroidectomy with or without lymph node dissection, we found that lymph node dissection in the central and lateral compartments, respectively, increased the risk of transient and permanent hypoparathyroidism and recurrent laryngeal nerves injuries.
Abstract
Background: Lymph node dissection (LND) in primary treatment of differentiated thyroid carcinoma is controversial. The aim of our retrospective study was to analyse the risk factors of post-thyroidectomy complications and to assess the morbidity of lymph node dissection, especially in the central neck compartment, since prophylactic central lymph node dissection has not been proven to bring an overall survival benefit. Methods: We performed a retrospective analysis of postoperative complications from 1547 consecutive patients with differentiated thyroid carcinoma in an academic department of endocrine surgery over a period of 10 years. Results: A total of 535 patients underwent lymph node dissection, whereas the other 1012 did not. The rate of postoperative hypoparathyroidism was higher in patients with LND (17.6% vs. 11.4%, p = 0.001). No significant difference in the rate of permanent hypoparathyroidism (2.4% vs. 1.3%, p = 0.096) was observed between these two groups. A multivariate analysis was performed. Female gender, ipsilateral and bilateral central LND (CLND), parathyroid autotransplantation, and the presence of the parathyroid gland on the resected thyroid were associated with transient hypoparathyroidism. Bilateral CLND and the presence of the parathyroid gland on specimen were associated with permanent hypoparathyroidism. The rate of transient recurrent laryngeal nerve (RLN) injury (15.3% vs. 5.4%, p < 0.001) and permanent RLN injury (6.5% vs. 0.9%, p < 0.001) were higher in the LND group. In multivariate analysis, ipsilateral and bilateral lateral LND (LLND) were the main predictive factors of transient and permanent RLN injury. Bilateral RLN injury (2.6% vs. 0.4%, p < 0.001), chyle leakage (2.4% vs. 0%, p < 0.001), other nerve injuries (2.2% vs. 0%, p < 0.001), and abscess (2.4% vs. 0.5%, p = 0.001) were higher in the patients with LND. Conclusions: The surgical technique and the extent of lymph node dissection during surgery for thyroid carcinoma increase postoperative morbidity. A wider knowledge of lymph-node-dissection-related complications associated with thyroid surgery could help surgeons to carefully evaluate the surgical and medical therapeutic options.
1. Introduction
Thyroid carcinoma is the most common endocrine cancer and its incidence has dramatically increased in recent decades all over the world [1]. Nowadays, total thyroidectomy (TT) has been accepted as the most efficient procedure for treating thyroid cancer. However, controversy remains regarding the optimal extent of thyroid surgery and lymph node dissection. TT with therapeutic lymph node dissection (LND) is recommended in patients with lymph node metastases in the neck identified on preoperative examination or at the time of surgery [2]. Nevertheless, the role of prophylactic LND in patients with N0 neck is still uncertain [3,4,5]. Indeed, TT with LND could decrease locoregional recurrence in patients with thyroid carcinoma [6,7,8,9] and could have some important prognostic values for accurate clinical staging and postoperative treatment [10]. However, LND does not seem to affect long-term survival [11,12]. Conversely, TT with LND is associated with a high incidence of transient or permanent hypoparathyroidism and increased risk of injury to the inferior recurrent laryngeal nerve, leading to transient or permanent vocal cord palsy [7,8,9]. Therefore, the aim of this study was to precisely characterise the morbidity of LND and to analyse the predictive risk factors of those relevant complications.
2. Patients and Methods
In this retrospective cohort study, we enrolled all consecutive patients with thyroid carcinoma who underwent total thyroidectomy in the Department of General and Endocrine Surgery of the University Hospital of Lille between 1 January 2000 and 31 December 2009. This research project was added to the register of data analysis of the University Hospital of Lille under the reference DEC22-226. The inclusion criteria combined (1) a diagnosis of thyroid carcinoma confirmed by pathology, whether or not malignancy was suspected prior to surgery by preoperative ultrasound and/or preoperative cytology, and (2) a total thyroidectomy, with or without LND in the central and/or lateral neck compartments. Patients were excluded when (1) a unilateral thyroidectomy was performed, (2) they had previous history of thyroid and/or parathyroid surgery, or (3) they had a associated diagnosis of hyperparathyroidism.
2.1. Operative Technique
All operations were performed by surgeons with different levels of experience and consisted of a total thyroidectomy after a cervical Kocher incision; the infrahyoid muscles were opened along the midline and muscles were divided as necessary. In all patients, every effort was made to identify and preserve the recurrent laryngeal nerves and the four parathyroid glands. When vascularization of a parathyroid gland appeared compromised, it was selectively resected and autotransplanted in the ipsilateral sternocleidomastoid muscle as previously described [13]. The extent of central neck and lateral neck dissection was determined in accordance with the American Thyroid Association thyroid cancer guidelines at the time of surgery [2]. Prophylactic lymph node dissection for the central neck compartment was performed in patients for suspect malignant thyroid tumor with clinically node-negative disease, primarily in the ipsilateral compartment as previously described [14]. Therapeutic central neck dissection (CND) was performed when abnormal lymphadenopathy was detected during the preoperative or intraoperative examination. In patients with suspected malignant thyroid tumor, lymph node sampling (LNS) for frozen section could be performed in the ipsilateral central or lateral compartments [15]. Lateral neck dissection was performed only in patients with cytology-proven metastatic lymph nodes in the lateral neck, including levels II–V.
2.2. Follow-Up
Postoperative follow-up was previously described in Pattou et al. [13]. Briefly, vocal fold function was assessed in all patients by laryngoscopy examination before and immediately after surgery. Recurrent laryngeal nerve injuries were defined as a dysfunction or a total absence of vocal cord mobility compared to the contralateral one based on preoperative fiberoptic laryngoscopy. All vocal fold palsies lasting for more than one year were considered as permanent. The fasting serum calcium and serum phosphorus levels were measured daily before and after surgery until the day of hospital discharge. Hypoparathyroidism was defined as a serum calcium level under 8.0 mg/dL (2 mmol/L) on at least two consecutive measurements and was systematically treated with calcium supplementation. Permanent hypoparathyroidism was defined by the requirement for vitamin D or calcium supplementation (or both) to maintain eucalcemia 1 year after thyroidectomy. All patients were also systematically examined postoperatively for other relevant complications such as hematoma, chyle leakage and nerve damage (spinal accessory nerve, vagus nerve, phrenic nerve, and/or sympathetic trunk).
2.3. Statistical Analysis
Continuous variables were expressed as means with standard deviations, and compared with Student’s t-test. Nominal data were compared using a Chi-squared test or Fisher’s exact test, as appropriate. Predictive factors of surgical complications with a p value < 0.2 in univariate analysis were considered for multivariate model using a downward stepwise binary logistic regression analysis. Differences were considered significant for p values inferior to 0.05. All statistical analysis was conducted with SPSS v20 software (SPSS, Chicago, IL, USA).
3. Results
3.1. Patient Characteristics
The characteristics of the 1547 patients with thyroid carcinoma confirmed by histological analysis of the surgical specimen who underwent total thyroidectomy with or without LND are summarized in Table 1. Among them, 535 (34.6%) patients had LND. LND in the central compartment consisted of 39 (2.5%) ipsilateral central lymph nodes sampling (CLNS), 147 (9.5%) ipsilateral CLND, and 194 (12.5%) bilateral CLND. LND in the lateral compartment consisted of 64 (4.1%) ipsilateral lateral lymph nodes sampling (LLNS), 124 (8.0%) bilateral LLNS, 137 (8.9%) ipsilateral LLND and 57 (3.7%) bilateral LLND. The surgery-related postoperative morbidity is listed in Table 2.
3.2. Postoperative Hypoparathyroidism
Transient or permanent hypoparathyroidism occurred, respectively, in 209 (13.5%) and 26 (1.7%) patients (Table 2). The rate of transient hypoparathyroidism was higher in patients with LND in comparison with those without LND (p < 0.001) (Table 2). Univariate analysis of predictive factors associated with transient hypoparathyroidism is presented in Table 3. Briefly, we observed that patients who presented with transient postoperative hypoparathyroidism underwent more ipsi (p = 0.003) or bilateral (p < 0.001) CLND and ipsilateral LLND (p = 0.001). Noteworthily, parathyroid glands were more frequently autotransplanted (p < 0.001) or present on the surgical specimen (p < 0.001) in patients with transient hypoparathyroidism, while the number of parathyroid glands seen during the intervention were similar between the two study groups (p = 0.064). Because most of the patients who were submitted to LLND had an ipsi or bilateral CLND, we performed a multivariate analysis to precisely determine the role of each type of LND and other cofactors on the onset of transient postoperative hypoparathyroidism. We found that female gender (p < 0.001), ipsilateral CLND (p = 0.025), bilateral CLND (p < 0.003), parathyroid autotransplantation (p = 0.007) and the presence of parathyroid glands on the resected thyroid (p < 0.001) were independent predictive factors associated with transient hypoparathyroidism (Table 4). By including all types of lymph node dissection (i.e., lymph node sampling plus lymph node dissection), no significant difference in the rate of permanent hypoparathyroidism was observed between the two groups (p = 0.096) (Table 2). However, univariate analysis of predictive factors associated with permanent hypoparathyroidism revealed that patients with permanent postoperative hypoparathyroidism had more bilateral CLND than those with normal parathyroid function (p = 0.001) (Table 3). Parathyroid glands were also more frequently retrieved after surgical specimen examination in patients with permanent hypoparathyroidism (p < 0.001). Multivariate analysis confirmed that bilateral CLND (p = 0.033) and the presence of the parathyroid gland on the resected thyroid (p = 0.002) were the two major independent predictive factors of permanent postoperative hypoparathyroidism (Table 4).
3.3. Postoperative Recurrent Laryngeal Nerve Injuries
Among all patients studied, transient, permanent or bilateral RLN injuries occurred, respectively, in 137 (8.9%), 44 (2.8%) and 18 (1.1%) patients (Table 2). Patients submitted to total thyroidectomy with LND presented with higher rates of transient (15.3% vs. 5.4%, p < 0.001), permanent (6.5% vs. 0.9%, p < 0.001) or bilateral (2.6% vs. 0.4%, p < 0.001) RLN injuries than those operated on thyroidectomy alone (Table 2). Univariate analysis of predictive factors associated with transient, permanent or bilateral RLN injuries are presented in Table 5. In summary, we observed that ipsilateral and bilateral CLND both increased the rate of transient (p < 0.001 and p < 0.001, respectively) or permanent RLN injuries (p = 0.008 and p < 0.001, respectively) (Table 5), whereas only bilateral CLND increased the rate of bilateral RLN injuries (p < 0.001) (Table 5). Concerning lateral lymph node dissection, we found that ipsilateral and bilateral LLND increased the rate of transient (p < 0.001 and p < 0.001, respectively) or permanent RLN injuries (p < 0.001 and p < 0.001, respectively) (Table 5). Noteworthily, bilateral LLNS also lead to more transient RLN injuries (p = 0.020) (Table 5). As for central lymph node dissection, only bilateral LLND increased the rate of bilateral RLN injuries (p < 0.001) (Table 5). In multivariate analysis, we demonstrated that bilateral LLND, which exposes both vagus nerves, was the major independent predictive factor of transient (p < 0.001), permanent (O p < 0.001) or bilateral (p < 0.001) RLN injuries (Table 6). In patients who presented with bilateral RLN injuries, initial intervention included thyroidectomy with CLND (n = 13) and/or ipsilateral (n = 3) or bilateral (n = 7) LLND. Resection of an upper recurrent nerve was performed on one patient. Prolonged intubation of 48.0 ± 16.9 h postoperatively was required in five patients. Tracheotomy was performed on one patient, who died 149 days after the surgical procedure due to complications of his tracheotomy. Histopathological analysis revealed papillary cancer (n = 12), follicular cancer (n = 2), medullary thyroid cancer (n = 3), and poorly differentiated cancer (n = 1). The mean duration of hospitalisation was 9.8 ± 5.8 days.
3.4. Compressive Hematoma
Ten patients (0.6%) presented with postoperative compressive hematoma (Table 1). No patients died. The initial surgical procedure consisted of total thyroidectomy (n = 10) without LND (n = 9) or was associated with ipsilateral CLNS (n = 1). In 6 out of 10 cases, surgical indication was a multinodular goiter. The time to onset of the hematoma was 6.8 ± 13.1 h. All patients were re-operated on and the origin of the bleeding was found in 8 out of 10 cases. The mean duration of hospitalisation was 5.9 ± 1.8 days.
3.5. Chyle Leakage
Thirteen (2.2%) patients had chyle leakage (Table 1). The initial intervention included ipsilateral CLND (n = 13), ipsilateral LLNS (n = 1), or ipsilateral (n = 10) or bilateral (n = 2) LLND. Fistula was diagnosed, on average, 1.6 ± 0.2 days after the procedure. In one patient, chyle leakage was identified during the intervention. The mean chyle flow observed in the drain on the first postoperative day was 175 ± 37.4 mL. Management began as soon as the diagnosis was suspected by a conservative treatment (compression dressing associated with a diet rich in medium-chain triglycerides). The mean duration of drainage was 8.1 ± 1.5 days. In one patient, conservative treatment failed despite the administration of somatostatin analogs from day 7 and thoracic canal ligation by thoracoscopy was performed at day 20 postoperatively. The mean hospital stay was 8.5 ± 1.9 days. No recurrence was observed.
3.6. Other Nerve Palsy
Ten patients (0.6%) had nerve palsy other than recurrent laryngeal nerve injury (Table 1). Lymph node dissection included unilateral CLND (n = 10) associated with ipsilateral (n = 8) or bilateral LLND (n = 2). Nerve damage was spinal nerve injury (n = 5) or Claude Bernard Horner’s syndrome (n = 5).
4. Discussion
In our study, we demonstrated that central lymph node dissection, and more particularly bilateral CLND, drastically increases the risk of transient and permanent postoperative hypoparathyroidism, while lateral lymph node dissection exposes a higher risk of recurrent laryngeal nerve palsy. Nowadays, the vast majority of patients with a diagnosis of thyroid cancer are submitted to total thyroidectomy. A high proportion also receive neck lymph node dissection even in the absence of documented lymph node metastases [16]. Noteworthily, there is little direct evidence of clinical benefit in terms of lower recurrence or mortality rates for thyroidectomy with prophylactic CLND over thyroidectomy alone, especially for the management of papillary thyroid carcinoma [3,4,5,6]. On the other hand, clear and consistent evidence demonstrates greater morbidity from neck lymph node dissection [7,8,9]. Thus, surgeons should balance the oncologic benefit of lymph node dissection with the risk of surgical complications. Among these, hypoparathyroidism remains the most common complication after thyroid surgery [17]. In our study, the rate of postoperative transient or permanent hypoparathyroidism was in the lower range of the incidence found in the literature, and consistent with a previous report from our department [13]. In a systematic review and meta-analysis of 115 studies, the median (IQR) incidence of temporary and long term post-surgical hypocalcaemia was 27% (19–38%) and 1% (0–3%), respectively [18]. Postoperative hypocalcaemia also represents a major cause of prolonged outpatient follow-up and hospital care cost [19]. In addition, the quality of life in patients with permanent hypoparathyroidism who require long-term calcium and vitamin D supplementation seems to be seriously affected [20]. The primary causes of postoperative hypoparathyroidism are direct injury, devascularisation, venous engorgement, or inadvertent excision of the parathyroid gland [21]. If the removal of one single parathyroid gland does not increase the risk of postoperative hypocalcaemia, the risk of hypocalcaemia is increased when fewer than three glands have been preserved in situ [13] and could lead to permanent hypoparathyroidism [22]. As demonstrated in a meta-analysis of over 3000 patients [23], we also observed in our cohort that transient hypocalcaemia was more common in patients undergoing ipsi or bilateral CLND in comparison with thyroidectomy alone. Moreover, multivariate analysis confirmed that CLND was an independent predictive factor of transient hypoparathyroidism. We also showed in the present multivariate analysis that bilateral CLND was associated with a (OR = 2.69, IC95% [1.083–6.695], p = 0.033) higher risk of permanent hypocalcaemia (Table 4). Similar results also have been observed in a large series of 1087 patients submitted to thyroidectomy alone, or thyroidectomy plus ipsilateral or bilateral CLND, in which the authors demonstrated that bilateral CLND had a significantly higher rate of permanent hypoparathyroidism [24]. Recently, Salem et al. also demonstrated that CLND was a risk factor for permanent hypoparathyroidism (OR = 3.74, IC95% [1.46–9.59]), based on the use of combined therapy 6 months after surgery [25]. Interestingly, they also found that node negativity was associated with a risk of permanent hypoparathyroidism (OR = 3.08, IC95% [1.31–7.25]), suggesting that an extensive exploration of the central neck compartment might increase the risk of unintentional removal of the lower parathyroid glands. Our results also highlight the importance of in situ parathyroid gland preservation during total thyroidectomy, with or without LND, to avoid postoperative hypocalcaemia [26]. Here, we showed that the presence of parathyroid glands on the specimen is the main determinant of permanent postoperative hypoparathyroidism (OR = 4.42, IC95% [1.727–11.291], p = 0.002) (Table 4). Thus, visual identification of all parathyroid glands and the complex vascular structures surrounding the parathyroid gland have been proposed to guarantee normal postoperative parathyroid function [27]. For that purpose, novel promising techniques using augmented and virtual reality in surgery have been developed to better identify parathyroid glands and their vascularization. Recently, Vidal Fortuny et al. demonstrated in a randomised clinical trial that intraoperative parathyroid gland angiography with indocyanine green (ICG) could predicate postoperative hypoparathyroidism and obviate the need for systematic blood tests and oral calcium supplementation [28]. In addition, a careful examination of the surgical specimen intraoperatively should also be performed to allow parathyroid auto-transplantation, if necessary, and to avoid inadvertent parathyroidectomy during thyroid surgery [29].
Likewise, RLN injury is a rare but potentially severe and life-threatening complication [30]. Symptoms can range from almost undetectable hoarseness in unilateral palsy to stridor and acute airway obstruction in bilateral damage [31]. Currently, RLN injury represents the main cause of medicolegal litigation after thyroid surgery [32]. Incidence of transient RLN injuries ranges from 1% to 30%, whereas permanent injuries are documented in 0.5% to 5% of patients, according to various studies and depending on the stringency of the postoperative laryngoscopy examination [33]. In our cohort, transient and permanent RLN injuries appeared in 8.9% and 2.8% of patients, respectively; well in line with previous published results [34]. Post-surgical vocal cord palsy is mainly caused by different intraoperative actions such as cutting, clamping, stretching, compressing, and heating [35]. Over the years, surgical strategy has advanced from non-visualization and avoidance of the RLN to the modern surgical technique of capsular dissection and direct visualization of the RLN to prevent neural damage [36]. As demonstrated by Misiolek et al., recurrent laryngeal nerves were not identified intraoperatively in 50% of patients with bilateral RLN injury after surgery [37]. The difficulty of dissecting and finding the RLN during cervical surgery also lies in the great anatomic variability of its position and sometimes is due to an early division in branches. Many methods have been recently described to help detect the RLN, such as the use of intraoperative neuromonitoring [38]. In our study, we focused on the impact of LND on postoperative RLN function. For that purpose, we chose to review an historical cohort before implementing intraoperative neuromonitoring to avoid bias due to the utilization of this novel technique. Thus, we found that transient or permanent RLN injuries were more frequent in patients who received ipsi or bilateral CLND, with or without LLND. However, multivariate analysis revealed that ipsi or bilateral CLND were not independent predictive factors of RLN injury. Interestingly, the study by Giordiano et al. showed that neither ipsi nor bilateral CLND increased the rate of transient or permanent hoarseness [24]. These results were also confirmed in a recent meta-analysis by Zhao et al., in which the risk of transient or permanent RLN injury was similar between thyroidectomy alone and thyroidectomy plus CLND [6]. Taken together, these results suggest that dissection of the recurrent laryngeal nerve during CLND does not provide further RLN injury than the dissection of the recurrent laryngeal nerve throughout thyroidectomy, and other surgical aspects should be taken apart. Lateral cervical neck dissection is commonly indicated in patients with proven lateral neck node involvement [2]. LLND, which normally entails levels IIa through Vb, exposes the patient to an increased risk of neural, vascular or lymphatic injuries. In the literature, a lack of evidence still remains concerning the impact of LLND on postoperative complications. Several retrospective studies showed increased complication rates in patients who had undergone LLND [39]. However, these results should be interpreted with caution. Indeed, most of these studies have compared the rate of complication between LND (i.e., CLND plus LLND) and no LND without making any distinction between central or lateral neck dissection [40,41,42,43,44,45,46]. Moreover, they do not, in their comparisons, precisely distinguish the different types of complications, surprisingly including hypocalcaemia, which is primarily due to CLND. In the present study, we obviously demonstrate that LLND and more especially bilateral LLND is a major contributor of post-surgical transient (OR = 10.434, IC95% [4.943–22.026], p < 0.001), definitive (OR = 31.97, IC95% [13.787–74.13], p < 0.001), and bilateral (OR = 6.512, IC95% [1.695–25.021], p = 0.006) vocal cord palsy (Table 6). These results suggest that particular attention must be paid during the dissection of the vagus nerve to prevent surgical damage and to reduce vocal cord palsy. Furthermore, a surgical procedure that exposes both recurrent laryngeal nerve and both vagus nerves represents a major risk of bilateral RLN injury and should be performed by an experienced surgeon in a tertiary referral center.
5. Conclusions
Lymph node dissection during thyroidectomy in patients with differentiated carcinoma significantly increases postoperative morbidity. A wider knowledge of lymph-node-dissection-related complications associated with thyroid surgery could help surgeons to carefully evaluate the surgical and medical therapeutic options and to be able to give the patient adequate information about the benefits and the risks of surgery.
Author Contributions
Conceptualization, G.B. and F.P.; methodology, F.P.; software, G.B.; vali-dation, G.B., A.J., C.M., B.C., C.D.C., E.L., G.L., S.B., S.A., B.B., M.-C.V., R.C. and F.P.; formal analysis, G.B.; investigation, G.B.; resources, G.B., A.J., C.M., B.C., C.D.C., E.L., A.B., G.L., S.B., S.A., B.B., M.-C.V., R.C. and F.P.; data curation, G.B.; writing—original draft preparation, G.B., A.J., C.M., B.C. and F.P.; writing—review and editing, G.B., A.J., C.M., B.C. and F.P.; visualization, G.B.; supervision, F.P.; project administration, F.P.; funding acquisition, none. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review board and the register of data analysis of the University Hospital of Lille under the reference DEC22-226.
Informed Consent Statement
Patient consent was waived due to the large number of patients, the period of the data collected and the cost and time of providing the information in accordance with the register of data analysis of the University Hospital of Lille under the reference DEC22-226.
Data Availability Statement
The data are not publicly available due to the facility’s privacy policy.
Conflicts of Interest
The authors have no conflict of interest to declare.
References
- Vaccarella, S.; Franceschi, S.; Bray, F.; Wild, C.P.; Plummer, M.; dal Maso, L. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N. Engl. J. Med. 2016, 375, 614–617. [Google Scholar] [CrossRef]
- Haugen, B.R.; Alexander, E.K.; Bible, K.C.; Doherty, G.M.; Mandel, S.J.; Nikiforov, Y.E.; Pacini, F.; Randolph, G.W.; Sawka, A.M.; Schlumberger, M.; et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016, 26, 1–133. [Google Scholar] [CrossRef] [Green Version]
- Sippel, R.S.; Robbins, S.E.; Poehls, J.L.; Pitt, S.C.; Chen, H.; Leverson, G.; Long, K.L.; Schneider, D.F.; Connor, N.P. A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer. Ann. Surg. 2020, 272, 496–503. [Google Scholar] [CrossRef]
- Viola, D.; Materazzi, G.; Valerio, L.; Molinaro, E.; Agate, L.; Faviana, P.; Seccia, V.; Sensi, E.; Romei, C.; Piaggi, P.; et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study. J. Clin. Endocrinol. Metab. 2015, 100, 1316–1324. [Google Scholar] [CrossRef] [Green Version]
- Ahn, J.H.; Kwak, J.H.; Yoon, S.G.; Yi, J.W.; Yu, H.W.; Kwon, H.; Kim, S.J.; Lee, K.E. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma. Surgery 2022, 171, 182–189. [Google Scholar] [CrossRef]
- Zhao, W.; You, L.; Hou, X.; Chen, S.; Ren, X.; Chen, G.; Zhao, Y. The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis: pCND for the Locoregional Recurrence of Papillary Thyroid Cancer. Ann. Surg. Oncol. 2017, 24, 2189–2198. [Google Scholar] [CrossRef]
- Chen, L.; Wu, Y.H.; Lee, C.H.; Chen, H.A.; Loh, E.W.; Tam, K.W. Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis. World J. Surg. 2018, 42, 2846–2857. [Google Scholar] [CrossRef]
- Su, H.; Li, Y. Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: A meta-analysis. Braz. J. Otorhinolaryngol. 2019, 85, 237–243. [Google Scholar] [CrossRef]
- Zhao, W.J.; Luo, H.; Zhou, Y.M.; Dai, W.Y.; Zhu, J.Q. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis. Eur. J. Surg. Oncol. 2017, 43, 1989–2000. [Google Scholar] [CrossRef]
- Hartl, D.M.; Leboulleux, S.; Al Ghuzlan, A.; Baudin, E.; Chami, L.; Schlumberger, M.; Travagli, J.P. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann. Surg. 2012, 255, 777–783. [Google Scholar] [CrossRef]
- Adam, M.A.; Pura, J.; Gu, L.; Dinan, M.A.; Tyler, D.S.; Reed, S.D.; Scheri, R.; Roman, S.A.; Sosa, J.A. Extent of surgery for papillary thyroid cancer is not associated with survival: An analysis of 61,775 patients. Ann. Surg. 2014, 260, 601–605; discussion 605–607. [Google Scholar] [CrossRef] [Green Version]
- Nixon, I.J.; Wang, L.Y.; Ganly, I.; Patel, S.G.; Morris, L.G.; Migliacci, J.C.; Tuttle, R.M.; Shah, J.P.; Shaha, A.R. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br. J. Surg. 2016, 103, 218–225. [Google Scholar] [CrossRef] [Green Version]
- Pattou, F.; Combemale, F.; Fabre, S.; Carnaille, B.; Decoulx, M.; Wemeau, J.L.; Racadot, A.; Proye, C. Hypocalcemia following thyroid surgery: Incidence and prediction of outcome. World J. Surg. 1998, 22, 718–724. [Google Scholar] [CrossRef]
- El Khatib, Z.; Lamblin, J.; Aubert, S.; Arnalsteen, L.; Leteurtre, E.; Caiazzo, R.; Pattou, F.; Carnaille, B. Is thymectomy worthwhile in central lymph node dissection for differentiated thyroid cancer? World J. Surg. 2010, 34, 1181–1186. [Google Scholar] [CrossRef]
- Aubert, S.; Berdelou, A.; Gnemmi, V.; Behal, H.; Caiazzo, R.; D’Herbomez, M.; Pigny, P.; Wemeau, J.L.; Carnaille, B.; Renaud, F.; et al. Large sporadic thyroid medullary carcinomas: Predictive factors for lymph node involvement. Virchows Arch. 2018, 472, 461–468. [Google Scholar] [CrossRef]
- Haymart, M.R.; Miller, D.C.; Hawley, S.T. Active Surveillance for Low-Risk Cancers—A Viable Solution to Overtreatment? N. Engl. J. Med. 2017, 377, 203–206. [Google Scholar] [CrossRef] [Green Version]
- Genser, L.; Tresallet, C.; Godiris-Petit, G.; Li Sun Fui, S.; Salepcioglu, H.; Royer, C.; Menegaux, F. Randomized controlled trial of alfacalcidol supplementation for the reduction of hypocalcemia after total thyroidectomy. Am. J. Surg. 2014, 207, 39–45. [Google Scholar] [CrossRef]
- Edafe, O.; Antakia, R.; Laskar, N.; Uttley, L.; Balasubramanian, S.P. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br. J. Surg. 2014, 101, 307–320. [Google Scholar] [CrossRef]
- Bhattacharyya, N.; Fried, M.P. Assessment of the morbidity and complications of total thyroidectomy. Arch. Otolaryngol. Head Neck Surg. 2002, 128, 389–392. [Google Scholar] [CrossRef] [Green Version]
- Stack, B.C., Jr.; Bimston, D.N.; Bodenner, D.L.; Brett, E.M.; Dralle, H.; Orloff, L.A.; Pallota, J.; Snyder, S.K.; Wong, R.J.; Randolph, G.W. American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: Postoperative Hypoparathyroidism--Definitions and Management. Endocr. Pract. 2015, 21, 674–685. [Google Scholar] [CrossRef]
- Su, A.; Wang, B.; Gong, Y.; Gong, R.; Li, Z.; Zhu, J. Risk factors of hypoparathyroidism following total thyroidectomy with central lymph node dissection. Medicine 2017, 96, e8162. [Google Scholar] [CrossRef]
- Paek, S.H.; Lee, Y.M.; Min, S.Y.; Kim, S.W.; Chung, K.W.; Youn, Y.K. Risk factors of hypoparathyroidism following total thyroidectomy for thyroid cancer. World J. Surg. 2013, 37, 94–101. [Google Scholar] [CrossRef]
- Shan, C.X.; Zhang, W.; Jiang, D.Z.; Zheng, X.M.; Liu, S.; Qiu, M. Routine central neck dissection in differentiated thyroid carcinoma: A systematic review and meta-analysis. Laryngoscope 2012, 122, 797–804. [Google Scholar] [CrossRef]
- Giordano, D.; Valcavi, R.; Thompson, G.B.; Pedroni, C.; Renna, L.; Gradoni, P.; Barbieri, V. Complications of central neck dissection in patients with papillary thyroid carcinoma: Results of a study on 1087 patients and review of the literature. Thyroid 2012, 22, 911–917. [Google Scholar] [CrossRef]
- Salem, F.A.; Bergenfelz, A.; Nordenstrom, E.; Almquist, M. Central lymph node dissection and permanent hypoparathyroidism after total thyroidectomy for papillary thyroid cancer: Population-based study. Br. J. Surg. 2021, 108, 684–690. [Google Scholar] [CrossRef]
- Lorente-Poch, L.; Sancho, J.J.; Ruiz, S.; Sitges-Serra, A. Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br. J. Surg. 2015, 102, 359–367. [Google Scholar] [CrossRef]
- Sadowski, S.M.; Vidal Fortuny, J.; Triponez, F. A reappraisal of vascular anatomy of the parathyroid gland based on fluorescence techniques. Gland Surg. 2017, 6, S30–S37. [Google Scholar] [CrossRef] [Green Version]
- Vidal Fortuny, J.; Sadowski, S.M.; Belfontali, V.; Guigard, S.; Poncet, A.; Ris, F.; Karenovics, W.; Triponez, F. Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery. Br. J. Surg. 2018, 105, 350–357. [Google Scholar] [CrossRef] [Green Version]
- Abboud, B.; Sleilaty, G.; Braidy, C.; Zeineddine, S.; Ghorra, C.; Abadjian, G.; Tabchy, B. Careful examination of thyroid specimen intraoperatively to reduce incidence of inadvertent parathyroidectomy during thyroid surgery. Arch. Otolaryngol. Head Neck Surg. 2007, 133, 1105–1110. [Google Scholar] [CrossRef] [Green Version]
- Hayward, N.J.; Grodski, S.; Yeung, M.; Johnson, W.R.; Serpell, J. Recurrent laryngeal nerve injury in thyroid surgery: A review. ANZ J. Surg. 2013, 83, 15–21. [Google Scholar] [CrossRef]
- Borel, F.; Christou, N.; Marret, O.; Mathonnet, M.; Caillard, C.; Bannani, S.; Drui, D.; Espitalier, F.; Blanchard, C.; Mirallie, E. Long-term voice quality outcomes after total thyroidectomy: A prospective multicenter study. Surgery 2018, 163, 796–800. [Google Scholar] [CrossRef]
- Abadin, S.S.; Kaplan, E.L.; Angelos, P. Malpractice litigation after thyroid surgery: The role of recurrent laryngeal nerve injuries, 1989–2009. Surgery 2010, 148, 718–723. [Google Scholar] [CrossRef] [PubMed]
- Joliat, G.R.; Guarnero, V.; Demartines, N.; Schweizer, V.; Matter, M. Recurrent laryngeal nerve injury after thyroid and parathyroid surgery: Incidence and postoperative evolution assessment. Medicine 2017, 96, e6674. [Google Scholar] [CrossRef] [PubMed]
- Blanchard, C.; Pattou, F.; Brunaud, L.; Hamy, A.; Dahan, M.; Mathonnet, M.; Volteau, C.; Caillard, C.; Durand-Zaleski, I.; Mirallié, E.; et al. Randomized clinical trial of ultrasonic scissors versus conventional haemostasis to compare complications and economics after total thyroidectomy (FOThyr). BJS Open 2017, 1, 2–10. [Google Scholar] [CrossRef]
- Rosato, L.; Avenia, N.; Bernante, P.; de Palma, M.; Gulino, G.; Nasi, P.G.; Pelizzo, M.R.; Pezzullo, L. Complications of thyroid surgery: Analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J. Surg. 2004, 28, 271–276. [Google Scholar] [CrossRef] [PubMed]
- Delbridge, L. Total thyroidectomy: The evolution of surgical technique. ANZ J. Surg. 2003, 73, 761–768. [Google Scholar] [CrossRef]
- Misiolek, M.; Waler, J.; Namyslowski, G.; Kucharzewski, M.; Podwinski, A.; Czecior, E. Recurrent laryngeal nerve palsy after thyroid cancer surgery: A laryngological and surgical problem. Eur. Arch. Otorhinolaryngol. 2001, 258, 460–462. [Google Scholar] [CrossRef]
- Schneider, R.; Randolph, G.; Dionigi, G.; Barczynski, M.; Chiang, F.Y.; Triponez, F.; Vamvakidis, K.; Brauckhoff, K.; Musholt, T.J.; Almquist, M.; et al. Prospective study of vocal fold function after loss of the neuromonitoring signal in thyroid surgery: The International Neural Monitoring Study Group’s POLT study. Laryngoscope 2016, 126, 1260–1266. [Google Scholar] [CrossRef]
- Madenci, A.L.; Caragacianu, D.; Boeckmann, J.O.; Stack, B.C., Jr.; Shin, J.J. Lateral neck dissection for well-differentiated thyroid carcinoma: A systematic review. Laryngoscope 2014, 124, 1724–1734. [Google Scholar] [CrossRef]
- Bardet, S.; Malville, E.; Rame, J.P.; Babin, E.; Samama, G.; de Raucourt, D.; Michels, J.J.; Reznik, Y.; Henry-Amar, M. Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur. J. Endocrinol. 2008, 158, 551–560. [Google Scholar] [CrossRef]
- Buckwalter, J.A.; Thomas, C.G., Jr. Selection of surgical treatment for well differentiated thyroid carcinomas. Ann. Surg. 1972, 176, 565–578. [Google Scholar] [CrossRef] [PubMed]
- Chung, Y.S.; Kim, J.Y.; Bae, J.S.; Song, B.J.; Kim, J.S.; Jeon, H.M.; Jeong, S.S.; Kim, E.K.; Park, W.C. Lateral lymph node metastasis in papillary thyroid carcinoma: Results of therapeutic lymph node dissection. Thyroid 2009, 19, 241–246. [Google Scholar] [CrossRef]
- Mazzaferri, E.L.; Young, R.L. Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients. Am. J. Med. 1981, 70, 511–518. [Google Scholar] [CrossRef]
- Roh, J.L.; Park, J.Y.; Park, C.I. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: Pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann. Surg. 2007, 245, 604–610. [Google Scholar] [CrossRef] [PubMed]
- Shen, W.T.; Ogawa, L.; Ruan, D.; Suh, I.; Duh, Q.Y.; Clark, O.H. Central neck lymph node dissection for papillary thyroid cancer: The reliability of surgeon judgment in predicting which patients will benefit. Surgery 2010, 148, 398–403. [Google Scholar] [CrossRef]
- Hu, D.; Zhou, J.; He, W.; Peng, J.; Cao, Y.; Ren, H.; Mao, Y.; Dou, Y.; Xiong, W.; Xiao, Q.; et al. Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma. World J. Surg. Oncol. 2018, 16, 30. [Google Scholar] [CrossRef] [PubMed]
Table 1.
Clinical, surgical and histological characteristics in patients who underwent total thyroidectomy with or without lymph node dissection for thyroid cancer.
Table 1.
Clinical, surgical and histological characteristics in patients who underwent total thyroidectomy with or without lymph node dissection for thyroid cancer.
| No Lymph Node Dissection n = 1012 | With Lymph Node Dissection n = 535 | Total n = 1547 | p | |
|---|---|---|---|---|
| Patient characteristics | ||||
| Female sex | 822 (81.2) | 371 (69.3) | 1193 (77.1) | <0.001 |
| Age (yr) | 50.9 ± 13.4 | 45.8 ± 16.0 | 49.1 ± 14.5 | <0.001 |
| Cervicotomy | 12 (1.2) | 24 (4.5) | 36 (2.3) | <0.001 |
| Cervical radiotherapy | 5 (0.5) | 2 (0.4) | 7 (0.5) | 0.738 |
| Indication of thyroidectomy | ||||
| Benign goiter | 848 (83.8) | 43 (8) | 891 (57.6) | <0.001 |
| Toxic nodule or goiter | 136 (13.4) | 1 (0.2) | 137 (8.9) | |
| Suspect thyroid nodule | 28 (2.8) | 491 (91.8) | 519 (33.5) | |
| Surgery | ||||
| Thyroid weight (gr) | 61.7 ± 52.4 | 37.3 ± 34.4 | 53.7 ± 48.6 | <0.001 |
| Number of parathyroid glands seen | 3.2 ± 0.8 | 3.2 ± 0.8 | 3.2 ± 0.5 | 0.348 |
| Number of parathyroid glands autotransplanted | 0.1 ± 0.3 | 0.4 ± 0.7 | 0.2 ± 0.5 | <0.001 |
| Histology | ||||
| Micro-papillary thyroid cancer | 688 (68) | 92 (17.2) | 780 (50.4) | <0.001 |
| Papillary thyroid cancer | 253 (25) | 324 (60.6) | 577 (37.3) | |
| Follicular thyroid cancer | 62 (6.1) | 36 (6.7) | 98 (6.3) | |
| Medullary thyroid cancer | 4 (0.4) | 79 (14.8) | 83 (5.4) | |
| Poorly differentiated cancer | 3 (0.3) | 3 (0.6) | 6 (0.4) | |
| Tumor size (mm) | 9.5 ± 14.0 | 21.3 ± 20.5 | 13.6 ± 17.4 | <0.001 |
| Stade T | ||||
| T1 | 863 (85.3) | 282 (52.7) | 1145 (74) | <0.001 |
| T2 | 86 (8.5) | 98 (18.3) | 184 (11.9) | |
| T3–T4 | 62 (6.1) | 155 (29) | 217 (14) | |
| Stade N | ||||
| N0 | 0 (0) | 136 (40) | 136 (13.8) | <0.001 |
| N1a | 0 (0) | 48 (9) | 48 (3.1) | |
| N1b | 0 (0) | 166 (31) | 166 (10.7) | |
| Parathyroid glands on specimen | 40 (4) | 76 (14.2) | 116 (7.5) | <0.001 |
Data are presented as mean ± standard deviation or n (%). p values are derived from a Chi-squared test or Fisher’s exact test for nominal variables and from Student’s t-test for continuous variables.
Table 2.
Surgical complications in patients who underwent total thyroidectomy with or without lymph node dissection for thyroid cancer.
Table 2.
Surgical complications in patients who underwent total thyroidectomy with or without lymph node dissection for thyroid cancer.
| No Lymph Node Dissection n = 1012 | With Lymph Node Dissection n = 535 | Total n = 1547 | p | |
|---|---|---|---|---|
| Recurrent laryngeal nerve injury | 68 (6.7) | 131 (24.5) | 199 (12.9) | <0.001 |
| Transient | 55 (5.4) | 82 (15.3) | 137 (8.9) | <0.001 |
| Permanent | 9 (0.9) | 35 (6.5) | 44 (2.8) | <0.001 |
| Bilateral | 4 (0.4) | 14 (2.6) | 18 (1.2) | <0.001 |
| Hypoparathyroidism | 128 (12.6) | 107 (20.0) | 235 (15.2) | <0.001 |
| Transient | 115 (11.4) | 94 (17.6) | 209 (13.5) | 0.001 |
| Permanent | 13 (1.3) | 13 (2.4) | 26 (1.7) | 0.096 |
| Other surgical complications | ||||
| Hematoma | 9 (0.9) | 1 (0.2) | 10 (0.6) | 0.101 |
| Chyle leakage | 0 (0) | 13 (2.4) | 13 (0.8) | <0.001 |
| Abscess | 5 (0.5) | 13 (2.4) | 18 (1.2) | 0.001 |
| Other nerve injuries | 0 (0) | 12 (2.2) | 12 (0.8) | <0.001 |
Data are presented as n (%). p values are derived from a Chi-squared test or Fisher’s exact test for nominal variables.
Table 3.
Univariate analysis of predictive factors associated with transient and permanent hypoparathyroidism.
Table 3.
Univariate analysis of predictive factors associated with transient and permanent hypoparathyroidism.
| No n = 1312 | Transient n = 209 | p | Permanent n = 26 | p′ | |
|---|---|---|---|---|---|
| Patient characteristics | |||||
| Female gender | 989 (75.4) | 182 (87.1) | <0.001 | 22 (84.6) | 0.360 |
| Age (years) | 49.8 ± 14.4 | 45.9 ± 14.4 | <0.002 | 41.1 ± 13.6 | 0.002 |
| Indication of thyroidectomy | |||||
| Benign goiter | 791 (60.3) | 91 (43.5) | <0.001 | 9 (34.6) | 0.028 |
| Toxic nodule or goiter | 108 (8.2) | 25 (12) | 4 (15.4) | ||
| Suspect thyroid nodule | 413 (31.5) | 93 (44.5) | 13 (50) | ||
| Surgery | |||||
| Thyroid weight (gr) | 53.8 ± 48.6 | 53.4 ± 48.9 | 0.926 | 50.6 ± 47.1 | 0.753 |
| Number of parathyroid glands seen | 3.2 ± 0.8 | 3.3 ± 0.8 | 0.064 | 3.2 ± 0.8 | 0.971 |
| Number of parathyroid glands autotransplantated | 0.2 ± 0.4 | 0.4 ± 0.7 | <0.001 | 0.3 ± 0.6 | 0.167 |
| Lymph node dissection | |||||
| Central lymph node dissection | |||||
| Ipsilateral CLNS | 33 (2.5) | 5 (2.4) | 1 | 1 (3.8) | 0.491 |
| Ipsilateral CLND | 113 (8.6) | 32 (15.3) | 0.003 | 2 (7.7) | 1 |
| Bilateral CLND | 137 (10.4) | 48 (23.0) | <0.001 | 9 (34.6) | 0.001 |
| Lateral lymph node dissection | |||||
| Ipsilateral LLNS | 54 (4.1) | 9 (4.3) | 0.852 | 1 (3.8) | 1 |
| Bilateral LLNS | 101 (7.7) | 20 (9.6) | 0.337 | 3 (11.5) | 0.448 |
| Ipsilateral LLND | 103 (7.9) | 32 (15.3) | 0.001 | 2 (7.7) | 1 |
| Bilateral LLND | 40 (3) | 12 (5.7) | 0.062 | 5 (19.2) | 0.001 |
| Histology | |||||
| Micropapillary thyroid cancer | 669 (51) | 98 (46.9) | 0.780 | 12 (46.2) | 0.915 |
| Papillary thyroid cancer | 483 (36.8) | 86 (41.1) | 11 (42.3) | ||
| Follicular thyroid cancer | 85 (6.5) | 12 (5.7) | 1 (3.8) | ||
| Medullary thyroid cancer | 70 (5.3) | 12 (5.7) | 2 (7.7) | ||
| Poorly differentiated cancer | 5 (0.4) | 1 (0.5) | 0 (0) | ||
| Tumor size (mm) | 13.3 ± 17.2 | 15.4 ± 19.3 | 0.116 | 13.5 ± 14.4 | 0.960 |
| Stade T | |||||
| T1 | 984 (75.1) | 143 (68.4) | 0.031 | 18 (69.2) | 0.453 |
| T2 | 155 (11.8) | 27 (12.9) | 2 (7.7) | ||
| T3–T4 | 172 (13.1) | 39 (18.7) | 6 (23.1) | ||
| Stade N | |||||
| N0 | 108 (8.2) | 22 (10.5) | 0.038 | 6 (23.1) | 0.414 |
| N1a | 32 (2.4) | 16 (7.7) | 0 (0) | ||
| N1b | 118 (9.0) | 43 (20.6) | 5 (19.2) | ||
| Parathyroid glands on specimen | 79 (6.0) | 28 (13.4) | <0.001 | 8 (30.8) | <0.001 |
Data are presented as mean ± standard deviation or n (%). p for comparison between no hypoparathyroidism and transient hypoparathyroidism. p′ for comparison between no hypoparathyroidism and permanent hypoparathyroidism. p and p′ values are derived from a Chi-squared test or Fisher’s exact test for nominal variables and from Student’s t-test for continuous variables.
Table 4.
Multivariate analysis of predictive factors associated with transient and permanent hypoparathyroidism.
Table 4.
Multivariate analysis of predictive factors associated with transient and permanent hypoparathyroidism.
| Odds Ratio (CI 95%) | p | |
|---|---|---|
| Transient hypoparathyroidism | ||
| Female gender | 2.48 (1.602– 3.843) | <0.001 |
| Ipsilateral CLND | 1.73 (1.07–2.786) | 0.025 |
| Bilateral CLND | 2.09 (1.293–3.377) | 0.003 |
| Parathyroid glands on specimen | 1.96 (1.467–2.617) | <0.001 |
| Parathyroid glands autotransplantated | 1.97 (1.207–3.216 | 0.007 |
| Permanent hypoparathyroidism | ||
| Age (years) | 0.970 (0.944–0.997) | 0.031 |
| Bilateral CLND | 2.692 (1.083–6.695) | 0.033 |
| Parathyroid glands on specimen | 4.416 (1.727–11.291) | 0.002 |
p values are derived from binary logistic regression model.
Table 5.
Univariate analysis of predictive factors associated with transient, permanent of bilateral RLN injuries.
Table 5.
Univariate analysis of predictive factors associated with transient, permanent of bilateral RLN injuries.
| No | Transient | p | Permanent | p′ | Bilateral | p″ | |
|---|---|---|---|---|---|---|---|
| n = 1348 | n = 137 | n = 44 | n = 18 | ||||
| Patient characteristics | |||||||
| Female gender | 1042 (77.3) | 109 (79.6) | 0.592 | 31 (70.5) | 0.278 | 11 (61.1) | 0.152 |
| Age (years) | 49.4 ± 14.2 | 45.6 ± 16.4 | 0.01 | 49.7 ± 14.4 | 0.876 | 54.2 ± 18.0 | 0.154 |
| Indication of thyroidectomy | |||||||
| Benign goiter | 832 (61.7) | 45 (32.8) | <0.001 | 9 (20.5) | <0.001 | 5 (27.8) | <0.001 |
| Toxic nodule or goiter | 122 (9.1) | 14 (10.2) | 1 (2.3) | 0 | |||
| Suspect thyroid nodule | 394 (29.2) | 78 (56.9) | 34 (77.3) | 13 (72.3) | |||
| Surgery | |||||||
| Thyroid weight (gr) | 54.1 ± 47.7 | 48.3 ± 44.9 | 0.189 | 48.4 ± 43.6 | 0.454 | 79.3 ± 113.8 | 0.374 |
| Lymph node dissection | |||||||
| Central lymph node dissection | |||||||
| Ipsilateral CLNS | 34 (2.5) | 5 (3.6) | 0.399 | 0 | 0.623 | 0 | 1 |
| Ipsilateral CLND | 107 (7.9) | 29 (21.2) | <0.001 | 9 (20.5) | 0.008 | 2 (11.1) | 0.649 |
| Bilateral CLND | 127 (9.4) | 34 (24.8) | <0.001 | 22 (50.0) | <0.001 | 11 (61.1) | <0.001 |
| Lateral lymph node dissection | |||||||
| Ipsilateral LLNS | 52 (3.9) | 7 (5.1) | 0.487 | 4 (9.1) | 0.097 | 1 (5.6) | 0.512 |
| Bilateral LLNS | 102 (7.6) | 19 (13.9) | 0.020 | 2 (4.5) | 0.728 | 1 (5.6) | 1 |
| Ipsilateral LLND | 92 (6.8) | 28 (20.4) | <0.001 | 14 (31.8) | <0.001 | 3 (16.7) | 0.124 |
| Bilateral LLND | 24 (1.8) | 13 (9.5) | <0.001 | 13 (29.5) | <0.001 | 7 (38.9) | <0.001 |
| Histology | |||||||
| Micropapillary thyroid cancer | 715 (53) | 53 (38.7) | <0.001 | 8 (18.2) | <0.001 | 3 (16.7) | <0.001 |
| Papillary thyroid cancer | 480 (35.6) | 69 (50.4) | 22 (50.0) | 9 (50.0) | |||
| Follicular thyroid cancer | 90 (6.7) | 4 (2.9) | 2 (4.5) | 2 (11.1) | |||
| Medullary thyroid cancer | 58 (4.3) | 11 (8) | 12 (27.3) | 3 (16.7) | |||
| Poorly differentiated cancer | 5 (0.4) | 0 (0) | 0 | 1 (5.6) | |||
| Tumor size (mm) | 12.6 ± 15.3 | 15.5 ± 15.7 | 0.036 | 27.2 ± 26.6 | 0.001 | 37.4 ± 65.1 | 0.125 |
| Stade T | |||||||
| T1 | 1026 (76.2) | 87 (63.5) | 0.003 | 21 (47.7 | <0.001 | 11 (61.1) | <0.001 |
| T2 | 156 (11.6) | 20 (14.6) | 8 (18.2) | 0 | |||
| T3–T4 | 165 (12.2) | 30 (21.9) | 15 (34.1) | 7 (38.9) | |||
| Stade N | |||||||
| N0 | 107 (7.9) | 16 (11.7) | 0.018 | 9 (20.5) | 0.028 | 4 (22.2) | 0.614 |
| N1a | 32 (2.4) | 12 (8.8) | 2 (4.5) | 2 (11.1) | |||
| N1b | 101 (7.5) | 36 (26.3) | 22 (50.0) | 7 (38.9) | |||
Data are presented as mean ± standard deviation or n (%). p for comparison between no RLN injury and transient RLN injuries. p′ for comparison between no RLN injury and permanent RLN injuries. p″ for comparison between no RLN injury and bilateral RLN injuries. p, p′ and p″ values are derived from a Chi-squared test or Fisher’s exact test for nominal variables and from Student’s t-test for continuous variables.
Table 6.
Multivariate analysis of predictive factors associated with transient, permanent or bilateral RLN injuries.
Table 6.
Multivariate analysis of predictive factors associated with transient, permanent or bilateral RLN injuries.
| Odd Ratio | p | |
|---|---|---|
| Transient RLN injuries | ||
| Ipsilateral CLND | 2.207 (1.273–3.825) | 0.005 |
| Bilateral LLNS | 2.738 (1.552–4.831) | 0.001 |
| Ipsilateral LLND | 3.049 (1.711–5.434) | <0.001 |
| Bilateral LLND | 10.434 (4.943–22.026) | <0.001 |
| Permanent RLN injuries | ||
| Ipsilateral LLND | 8.174 (3.794–17.612) | <0.001 |
| Bilateral LLND | 31.97 (13.787–74.13) | <0.001 |
| Bilateral RLN injuries | ||
| Bilateral CLND | 5.566 (1.566–19.784) | 0.008 |
| Bilateral LLND | 6.512 (1.695–25.021) | 0.006 |
| Tumor size | 1.019 (0.997–1.041) | 0.091 |
p values are derived from binary logistic regression model.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Baud, G.; Jannin, A.; Marciniak, C.; Chevalier, B.; Do Cao, C.; Leteurtre, E.; Beron, A.; Lion, G.; Boury, S.; Aubert, S.; et al. Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma. Cancers 2022, 14, 5462. https://0-doi-org.brum.beds.ac.uk/10.3390/cancers14215462
AMA Style
Baud G, Jannin A, Marciniak C, Chevalier B, Do Cao C, Leteurtre E, Beron A, Lion G, Boury S, Aubert S, et al. Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma. Cancers. 2022; 14(21):5462. https://0-doi-org.brum.beds.ac.uk/10.3390/cancers14215462
Chicago/Turabian StyleBaud, Gregory, Arnaud Jannin, Camille Marciniak, Benjamin Chevalier, Christine Do Cao, Emmanuelle Leteurtre, Amandine Beron, Georges Lion, Samuel Boury, Sebastien Aubert, and et al. 2022. "Impact of Lymph Node Dissection on Postoperative Complications of Total Thyroidectomy in Patients with Thyroid Carcinoma" Cancers 14, no. 21: 5462. https://0-doi-org.brum.beds.ac.uk/10.3390/cancers14215462
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
